Table 1.
Demographic data and clinical characteristics of patients
| PC group (n = 193) | T-tube group (n = 62) | P value | |
|---|---|---|---|
| Age (years) | 64 ± 15 | 66 ± 13 | 0.322 |
| Sex (male/female) | 79/114 | 24/38 | 0.756 |
| ASA (I/II/III) | 72/102/19 | 22/35/5 | 0.855 |
| No. of comorbiditya, n (%) | |||
| ≤ 1 | 118 (61.14) | 41 (66.13) | 0.481 |
| ≥ 2 | 75 (38.86) | 21 (33.87) | |
| Presentations, n (%) | |||
| Jaundice | 161 (83.42) | 48 (77.42) | 0.285 |
| Right upper quadrant pain | 169 (87.56) | 51 (82.26) | 0.291 |
| Acute biliary pancreatitis | 18 (9.33) | 7 (11.29) | 0.651 |
| Cholangitis (mild) | 109 (56.48) | 36 (58.06) | 0.826 |
| Cholangitis (moderate) | 84 (43.52) | 26 (41.94) | 0.826 |
| Laboratory data | |||
| WBC (× 109/L) | 11.12 ± 4.54 | 11.73 ± 5.12 | 0.376 |
| ALT (U/L) | 181.81 ± 129.50 | 160.18 ± 157.12 | 0.279 |
| Total bilirubin (μmol/L) | 69.90 ± 47.67 | 66.67 ± 42.42 | 0.634 |
| Diameter of CBD (mm) | 12.27 ± 2.82 | 12.44 ± 2.45 | 0.664 |
| No. of CBD stone, n (%) | |||
| Single | 55 (28.50) | 15 (24.19) | 0.509 |
| Multiple | 138 (71.50) | 47 (75.81) | |
| Pathologic type of gallbladder, n (%) | |||
| Acute cholecystitis | 44 (22.80) | 15 (24.19) | 0.821 |
| Chronic cholecystitis | 149 (77.20) | 47 (75.81) |
ASA American Society of Anesthesiologists, WBC white blood cell, ALT alanine aminotransferase, CBD common bile duct
aArterial hypertension, heart diseases, pulmonary diseases and diabetes mellitus